Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DB26FU2QF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,379
Award facts
- Contract value 100% obligated
- $14,378.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,378.92 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy. This firm fixed-price delivery order, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, was issued without a set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company's DLA IDC serves as a global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order represents one of numerous competitively awarded transactions executed under the broader pharmaceutical prime vendor contract.
Quick answers
Who was awarded contract SPE2DB26FU2QF?
SPE2DB26FU2QF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FU2QF worth?
The government has obligated $14,379 on SPE2DB26FU2QF.
Is contract SPE2DB26FU2QF an order under another contract?
Yes. SPE2DB26FU2QF is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB26FU2QF competed?
The extent of competition for SPE2DB26FU2QF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award